주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Pharma
목록
(
총 :
1,467 )
기사목록 보기 형태
제목형
요약형
포토형
Samjin invests in Neurophet for strategic expansion into dementia and stroke markets
Lee Han-soo
2024.03.04 13:50
Yuhan’s Leclaza, GC Biopharma’s Alyglo win 'grand prize in new drug development'
Kim Chan-hyuk
2024.03.04 13:30
Hugel scores FDA approval for botulinum toxin Letybo after 3rd submission
Lee Han-soo
2024.03.04 11:01
Pharmbio Korea secures exclusive rights to distribute Clipper for ulcerative colitis treatment
Kim Kyoung-Won
2024.02.29 16:20
Sanofi Korea expands Dupixent indication to address chronic nodular pruritic rash
Kim Chan-hyuk
2024.02.29 15:09
Kolon Life Science appeals for Invossa's license reinstatement to Supreme Court
Lee Han-soo
2024.02.29 13:13
Celltrion applies for Actemra biosimilar CT-P47’s sales license in Korea
Korea Biomedical Review
2024.02.29 10:56
Korean government stalls access to PARP inhibitors for prostate cancer patients
Kim Yun-mi
2024.02.28 13:24
Based on improved global status, BeiGene targets US market in earnest
Kim Chan-hyuk
2024.02.27 14:47
Biliary tract cancer patients can now use Imfinzi at their own expense
Kim Yun-mi
2024.02.27 14:11
Roche Korea shares latest blood cancer treatment strategies using Columvi, Lunsumio
You Ji-young
2024.02.27 10:43
Medytox faces FDA rejection over non-animal liquid BTX product
Lee Han-soo
2024.02.26 15:54
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기